IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow
IGC Pharma will present seven scientific posters at the AAIC 2026 conference in London, showcasing its AI portfolio for Alzheimer's drug discovery. The centerpiece is the AHA platform, which reduced data harmonization time by 90% (from 28 to 2.5 hours) in a representative internal workflow involving 100 variables.
Key figures
- Calma enrollment status
- 100% baseline randomization target reached
- Manual processing hours
- 28
- Automated processing hours
- 2.5
- Harmonization time reduction
- 90%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.